DiogenX develops innovative biologics as new therapeutics options designed for diabetic patients.
Automatic translation

Technologies

  • REDBIOTECH

Activity area

  • HEALTHTECH
  • PHARMATECH
  • CLINIC
  • BIOTECH

Maturity stage

  • Early bird

Key information

Year of creation

2020

Workforce

< 10

Maturity stage

Early bird

Total fundraising amount

32 000 000 €

Last round table level

Investment

Total fundraising amount

32 000 000 €

Maximum round table reached

Date Amount Investors Round table
01/07/2020 4 500 000,00 €
31/05/2023 27 500 000,00 €